Skip to main content
Watch Insiders
HEPAHealthcare

Hepion Pharmaceuticals Inc (HEPA) Insider Trading

In the last 90 days, 6 Hepion Pharmaceuticals Inc (HEPA) insiders reported 6 open-market purchases totaling $835,000 and no sales. The most recent open-market purchase was reported on Sep 29, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$835,000
Corporate buyers
6
Latest transaction
Sep 29, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 29, 2026Danina FisherCorporate insiderOpen Market Purchase200,000$0.05$10,000
Aug 3, 2026Gary S. Stetz IICorporate insiderOpen Market Purchase500,000$0.05$25,000
Aug 3, 2026Gary S. StetzInterim CEOOpen Market Purchase2,000,000$0.05$100,000
Aug 3, 2026Michael J. PurcellCorporate insiderOpen Market Purchase2,000,000$0.05$100,000
Aug 3, 2026Sireesh AppajosyulaChief Operating OfficerOpen Market Purchase2,000,000$0.05$100,000
Aug 3, 2026Vincent S LoPrioreExecutive ChairmanOpen Market Purchase10,000,000$0.05$500,000
Apr 21, 2026Michael J. PurcellCorporate insiderOpen Market Purchase1,250,000$0.04$50,000
Apr 21, 2026Vincent S LoPrioreExecutive ChairmanOpen Market Purchase6,250,000$0.04$250,000
Apr 21, 2026Sireesh AppajosyulaCorporate insiderOpen Market Purchase1,250,000$0.04$50,000
Apr 21, 2026Gary S. StetzInterim CEOOpen Market Purchase1,250,000$0.04$50,000

Common questions

HEPA insider trading FAQ

Are HEPA insiders buying or selling?
Over the last 90 days, HEPA insiders were net buyers, reporting $835,000 of open-market purchases and $0.00 of sales.
When was the last HEPA insider purchase?
The most recent open-market purchase of Hepion Pharmaceuticals Inc stock by an insider was reported on Sep 29, 2026, one of 6 purchases in the last 90 days.
Where does HEPA insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Hepion Pharmaceuticals Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.